These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 11154267

  • 1. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J.
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [Abstract] [Full Text] [Related]

  • 2. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G.
    Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
    [Abstract] [Full Text] [Related]

  • 3. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 4. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 5. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.
    Blood; 2000 Oct 15; 96(8):2746-54. PubMed ID: 11023508
    [Abstract] [Full Text] [Related]

  • 6. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
    Wang W, Smith R, Safe S.
    Arch Biochem Biophys; 1998 Aug 15; 356(2):239-48. PubMed ID: 9705214
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.
    Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250
    [Abstract] [Full Text] [Related]

  • 8. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I, Polyak K, Iavarone A, Massagué J.
    Genes Dev; 1995 Aug 01; 9(15):1831-45. PubMed ID: 7649471
    [Abstract] [Full Text] [Related]

  • 9. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C, Pratt MA.
    Mol Endocrinol; 1997 Aug 01; 11(9):1191-202. PubMed ID: 9259311
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of cyclin-dependent kinase inactivation by progestins.
    Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL.
    Mol Cell Biol; 1998 Apr 01; 18(4):1812-25. PubMed ID: 9528753
    [Abstract] [Full Text] [Related]

  • 11. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S, Foster JS, Bukovsky A, Diehl JA, Wimalasena J.
    Mol Carcinog; 2002 May 01; 34(1):45-58. PubMed ID: 12112322
    [Abstract] [Full Text] [Related]

  • 12. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
    Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS.
    Oncogene; 1998 Apr 23; 16(16):2141-50. PubMed ID: 9572495
    [Abstract] [Full Text] [Related]

  • 13. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.
    Jiang H, Chou HS, Zhu L.
    Mol Cell Biol; 1998 Sep 23; 18(9):5284-90. PubMed ID: 9710613
    [Abstract] [Full Text] [Related]

  • 14. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).
    Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, Enders GH.
    Mol Cell Biol; 1999 May 23; 19(5):3916-28. PubMed ID: 10207115
    [Abstract] [Full Text] [Related]

  • 15. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H, Ando A, Nagata Y, Pereira-Smith O, Smith JR, Ikeda K, Nakanishi M.
    Exp Cell Res; 1999 Dec 15; 253(2):503-10. PubMed ID: 10585273
    [Abstract] [Full Text] [Related]

  • 16. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS, Prall OW, Musgrove EA, Sutherland RL.
    J Biol Chem; 2000 Dec 08; 275(49):38221-9. PubMed ID: 10991938
    [Abstract] [Full Text] [Related]

  • 17. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK, Moraes RC, Singh U, Kittrell FS, Medina D.
    Cell Growth Differ; 2001 Jun 08; 12(6):285-95. PubMed ID: 11432803
    [Abstract] [Full Text] [Related]

  • 18. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ, Chang CY, Lin JK.
    Biochem Pharmacol; 2003 Jun 01; 65(11):1777-85. PubMed ID: 12781329
    [Abstract] [Full Text] [Related]

  • 19. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
    Planas-Silva MD, Weinberg RA.
    Mol Cell Biol; 1997 Jul 01; 17(7):4059-69. PubMed ID: 9199341
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG.
    Circulation; 2000 May 02; 101(17):2022-5. PubMed ID: 10790340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.